HDFC Life Insurance Company consolidated net profit rises 4.66% in the March 2026 quarter

HDFC Life Insurance Company consolidated net profit rises 4.66% in the March 2026 quarter


Sales rise 9.04% to Rs 25998.42 crore

Net profit of HDFC Life Insurance Company rose 4.66% to Rs 497.49 crore in the quarter ended March 2026 as against Rs 475.36 crore during the previous quarter ended March 2025. Sales rose 9.04% to Rs 25998.42 crore in the quarter ended March 2026 as against Rs 23842.99 crore during the previous quarter ended March 2025.

For the full year,net profit rose 5.61% to Rs 1912.32 crore in the year ended March 2026 as against Rs 1810.82 crore during the previous year ended March 2025. Sales rose 11.35% to Rs 77760.49 crore in the year ended March 2026 as against Rs 69836.97 crore during the previous year ended March 2025.

 ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.Sales25998.4223842.99 9 77760.4969836.97 11 OPM %0.421.58 1.461.18 PBDT536.69500.43 7 2057.171289.74 60 PBT536.69500.43 7 2057.171289.74 60 NP497.49475.36 5 1912.321810.82 6

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 16 2026 | 6:04 PM IST



Source link

HDFC Life Insurance Company consolidated net profit rises 4.66% in the March 2026 quarter

Alok Industries reports consolidated net loss of Rs 192.54 crore in the March 2026 quarter


Sales rise 3.15% to Rs 982.97 crore

Net Loss of Alok Industries reported to Rs 192.54 crore in the quarter ended March 2026 as against net loss of Rs 74.47 crore during the previous quarter ended March 2025. Sales rose 3.15% to Rs 982.97 crore in the quarter ended March 2026 as against Rs 952.96 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 744.11 crore in the year ended March 2026 as against net loss of Rs 816.43 crore during the previous year ended March 2025. Sales rose 0.16% to Rs 3714.79 crore in the year ended March 2026 as against Rs 3708.78 crore during the previous year ended March 2025.

 ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.Sales982.97952.96 3 3714.793708.78 0 OPM %0.36-2.44 0.75-2.44 PBDT-132.13-93.84 -41 -512.63-607.45 16 PBT-193.60-168.47 -15 -775.92-905.55 14 NP-192.54-74.47 -159 -744.11-816.43 9

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 16 2026 | 6:04 PM IST



Source link

HDFC Life Insurance Company consolidated net profit rises 4.66% in the March 2026 quarter

Rubicon Research to acquire 85% stake in Arinna Lifesciences for Rs 176 crore


Rubicon Research said that it has announced the acquisition of an 85% equity stake in Arinna Lifesciences, a branded pharmaceutical marketing company focused on the CNS and neuro-psychiatric segment in India.

The deal values Arinna at an enterprise value of Rs 200 crore on a cash and debt-free basis, with the purchase consideration for the stake pegged at around Rs 175.92 crore. The transaction will be executed entirely in cash and is subject to customary closing conditions and regulatory approvals.

Incorporated in 2013, Arinna operates a portfolio of over 60 brands across chronic therapies, including antiepileptics, antidepressants, antipsychotics and thymoleptics. The company has an established distribution network covering more than 4,000 prescribers across India through stockists, distributors and retail pharmacies.

 

Arinna reported turnover of Rs 71.5 crore in FY25, Rs 65.14 crore in FY24, and Rs 60.06 crore in FY23, indicating steady growth in its domestic formulations business.

Rubicon said the acquisition strengthens its strategy of expanding in chronic therapies, particularly the CNS segment, where it sees long-term growth potential. The company added that Arinnas distribution reach and product portfolio, along with its pipeline of specialty products and drug-device combinations, will support deeper access to patients and prescribers in India.

The acquisition is expected to be completed within one month of signing definitive agreements, or within mutually agreed timelines.

Commenting on the acquisition, Parag Sancheti, Rubicons Chief Executive Officer said The past decade has demonstrated the effectiveness of Rubicons playbook of R&D innovation, execution rigor and impeccable compliance standards which enabled us to scale our US revenues by over 32 x from FY15 to FY25 while delivering best-in-class return ratios.

Arinna now provides us a launchpad for deploying this playbook in the Indian domestic formulations market. Strategic M&A has always been integral to Rubicons strategy and our confidence stems from having successfully integrated and scaled acquisitions to foray into new segments such as US branded specialty in 2024 and nasal products development in 2020. I am pleased to welcome Vivek and the Arinna team to the Rubicon family.

Rubicon Research is a pharmaceutical formulations company focused on innovation-led research and development, with a growing portfolio of specialty products and drugdevice combination offerings aimed at regulated markets.

The companys consolidated net profit climbed 91.2% to Rs 72.79 crore on 51.73% increase in revenue from operations to Rs 475.52 crore in Q3 FY26 over Q3 FY25.

Shares of Rubicon Research rallied 5.57% to end at Rs 870.45 on the BSE.



Source link

HDFC Life Insurance Company consolidated net profit rises 4.66% in the March 2026 quarter

Nikkei hits record high as tech rally and ceasefire hopes boost sentiment


Japans Nikkei 225 Index jumped 2.38% to close at 59,518 on Thursday, reaching a new all-time high as optimism grew over a possible end to the Middle East conflict.

Reports suggest the United States and Iran may extend their two-week ceasefire to allow more time for peace talks, even as the Strait of Hormuz remains largely closed due to a dual blockade.

Japanese stocks also tracked strong gains on Wall Street, where solid bank earnings and renewed interest in technology shares lifted markets.

Technology and AI-related stocks led the rally, with gains in SoftBank Group (up 5.1%), Kioxia Holdings (up 4.5%), and Fujikura (up 4.7%).

 

Daikin Industries surged 9.1% after Elliott Investment Management revealed a stake in the company and pushed for changes to improve shareholder value.

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 16 2026 | 4:50 PM IST



Source link

HDFC Life Insurance Company consolidated net profit rises 4.66% in the March 2026 quarter

SG Finserve surges on strong Q4 earnings; PAT jumps 78% YoY


SG Finserve rallied 7.67% to Rs 499.80 after the company reported a robust performance for Q4 FY26, with standalone net profit rising 78% year-on-year to Rs 42.3 crore in Q4 FY26, compared with Rs 23.8 crore in the same quarter last year.

On a sequential basis, net profit increased 30% from Rs 32.5 crore reported in Q3 FY26.

Total income surged 95% YoY to Rs 105.7 crore in the quarter ended 31 March 2026, while it grew 23% quarter-on-quarter from Rs 85.8 crore.

Profit before tax in Q4 FY26 stood at Rs 56.2 crore, up by 81% YoY and 30% QoQ.

 

The company reported Net Interest Income (NII) of Rs 62.8 crore in Q4 FY26, up 77% YoY and 27% QoQ.

Operationally, the company maintained strong asset quality and efficiency, with a cost-to-income ratio below 15% and nil NPAs. For the full year, it reported a return on assets (RoA) of 4.80% and a return on equity (RoE) of 12% per annum.

During the quarter, SG Finserve raised Rs 316 crore through the conversion of share warrants, strengthening its capital base. The company said it remains well-capitalised, with total equity of Rs 1,460 crore and leverage of 1.9x, providing headroom for future growth.

The companys loan book reached an all-time high of Rs 3,936 crore as of 31 March 2026, registering a growth of 75% YoY and 23% QoQ. Gross disbursements crossed Rs 25,000 crore during the year, reflecting a 40% YoY increase.

The firm added that its strategy focuses on deepening and widening its business by strengthening existing customer relationships, acquiring new customers, expanding product offerings, and exploring adjacent financial services.

On a full-year basis, the companys standalone net profit jumped 58% YoY to Rs 127.7 crore, while total income climbed 96% YoY to Rs 333.7 crore in FY26 compared to FY25.

Meanwhile, the board has approved the appointment of Deepak Kumar as an additional director (non-executive, non-independent) and chairperson of the company, effective 16 April 2026, subject to shareholder approval.

SG Finserve (SGFL) is a tech-enabled RBI-registered non-banking finance company (NBFC) providing inclusive business financing solutions to channel partners dealers, distributors, retailers, buyers, suppliers, transporters/logistics, etc. of Indian corporates.



Source link

HDFC Life Insurance Company consolidated net profit rises 4.66% in the March 2026 quarter

Pace Digitek sizzles as FY26 order inflows hit Rs 6,460 crore on energy push


Pace Digitek rose 3.07% to Rs 173 after the company, along with its subsidiaries, reported robust order inflows of Rs 6,459.7 crore for FY2026, driven by strong momentum in its energy business.

The energy segment accounted for the bulk of the inflows at Rs 5,814.7 crore, while the telecom segment contributed Rs 645 crore. The company said the orders span key projects across both verticals, reflecting its expanding presence in battery energy storage systems (BESS) and renewable-linked opportunities.

Within the energy business, order inflows were supported by a diversified mix of contracts. Build Own Operate (BOO) projects contributed Rs 2,455 crore, accounting for 42% of the segments inflows and offering annuity-based revenue streams with long-term cash flow visibility. Engineering, Procurement and Construction (EPC) contracts made up Rs 3,048.4 crore, or 52%, providing execution visibility through utility-scale deployments. Supply contracts contributed Rs 311.4 crore, or about 6%, aiding near-term revenue generation and capacity utilisation.

 

The company and its subsidiaries secured projects from a mix of public and private sector clients, including KPTCL, KREDL, NTPC, SECI and MAHAGENCO, highlighting its growing participation in Indias energy transition.

The telecom segment continued to provide stability, with order inflows driven by operations and maintenance (O&M), equipment supply and infrastructure projects. Key clients include BSNL, Tata Teleservices, RailTel and Indian Railways. The company said this segment supports recurring revenue streams and near-term cash flow visibility, while ensuring operational continuity across multiple circles.

Overall, the order book offers multi-year execution visibility across both segments, with a rising share of energy-led projects. The company said its balanced mix of BOO, EPC and supply contracts positions it for sustained growth by combining long-term revenue visibility with near-term execution opportunities.

Commenting on the development, chairman and managing director Venugopal Rao Maddisetty said FY2026 marked a pivotal year for scaling the companys presence in energy, particularly in battery storage and renewable infrastructure. He added that strong order inflows reflect improving execution capabilities and continued trust from clients, while the diversified order mix supports disciplined and scalable growth.

Pace Digitek manufactures and supplies power electronic equipment and a wide range of electrical and electronic systems, along with their components. It also designs, trades, and delivers these solutions for use across industries such as energy and telecom infrastructure.

On a consolidated basis, Pace Digitek’s net profit rose 8.06% to Rs 75.84 crore while net sales rose 13.54% to Rs 643.97 crore in Q3 December 2025 over Q3 December 2024.



Source link

YouTube
Instagram
WhatsApp